Faheem Hasnain - 05 Jun 2025 Form 4 Insider Report for Kura Oncology, Inc. (KURA)

Role
Director
Signature
/s/ Teresa Bair, Attorney-in-fact for Faheem Hasnain
Issuer symbol
KURA
Transactions as of
05 Jun 2025
Transactions value $
$0
Form type
4
Filing time
06 Jun 2025, 16:05:11 UTC
Previous filing
24 Mar 2025
Next filing
02 Oct 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hasnain Faheem Director C/O KURA ONCOLOGY, INC., 12730 HIGH BLUFF DRIVE, SUITE 400, SAN DIEGO /s/ Teresa Bair, Attorney-in-fact for Faheem Hasnain 06 Jun 2025 0001352620

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction KURA Option to purchase common stock Award $0 +28.5K $0.00 28.5K 05 Jun 2025 Common Stock 28.5K $6.57 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 This option vests in full on the one year anniversary of the date of grant.